ALLMedicine™ Hypermagnesemia Center
Research & Reviews 96 results
https://doi.org/10.1111/nyas.14953
Annals of the New York Academy of Sciences; Houillier P, Lievre L et. al.
Jan 10th, 2023 - Magnesium is the fourth most abundant cation in the body. It plays a critical role in many biological processes, including the process of energy release. Paracellular transport of magnesium is mandatory for magnesium homeostasis. In addition to in...
https://doi.org/10.1177/09612033221149884
Lupus Yang W, Lian X et. al.
Jan 4th, 2023 - To assess the association of serum magnesium with infection in new-onset systemic lupus erythematosus (SLE) patients. We conducted a single-center retrospective cohort study of new-onset SLE patients from 2012 to 2021. The hospitalized SLE patient...
https://doi.org/10.1186/s12871-022-01903-2
BMC Anesthesiology; Tonai K, Katayama S et. al.
Nov 25th, 2022 - Hypomagnesemia reportedly has significant associations with poor clinical outcomes such as increased mortality and septic shock in patients with sepsis. Although the mechanism underlying these outcomes mostly remains unclear, some experimental dat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680141
BMJ Open; Leenders NHJ, Douma CE et. al.
Nov 22nd, 2022 - People treated with haemodialysis are at increased risk for all-cause and cardiovascular mortality. Plasma magnesium concentration has been inversely associated with these risks. Therefore, plasma magnesium may be a new modifiable risk factor and ...
https://clinicaltrials.gov/ct2/show/NCT02542319
Sep 6th, 2022 - Chronic kidney disease (CKD) is associated with increase cardiovascular morbidity and mortality independent of traditional cardiovascular risk factors due to increased vascular calcification. Epidemiological and experimental data suggest that hype...
Drugs 3 results see all →
Clinicaltrials.gov 4 results
https://clinicaltrials.gov/ct2/show/NCT02542319
Sep 6th, 2022 - Chronic kidney disease (CKD) is associated with increase cardiovascular morbidity and mortality independent of traditional cardiovascular risk factors due to increased vascular calcification. Epidemiological and experimental data suggest that hype...
https://clinicaltrials.gov/ct2/show/NCT04256369
Feb 3rd, 2022 - Methods Study design and centres This is a prospective, cohort, multi-centre study, to be conducted at King Faisal Specialist Hospital and Research Centre, (KFSH & RC), Riyadh. The study has been approved by KFSH&RC Office of Research Affairs repr...
https://clinicaltrials.gov/ct2/show/NCT02216877
Apr 28th, 2015 - Chronic kidney disease (CKD) is associated with increase cardiovascular morbidity and mortality independent of traditional cardiovascular risk factors due to increased vascular calcification. Epidemiological and experimental data suggest that hype...
https://clinicaltrials.gov/ct2/show/NCT01700998
Nov 4th, 2014 - Acute renal failure (ARF) is a serious and common complication in hospitalized patients, occurring in more than 25% of intensive care unit (ICU) patients. Hypomagnesemia is a common disorder, occurring in approximately 12% of hospitalized patients...
News 6 results
https://www.medpagetoday.com/hematologyoncology/othercancers/96220
Dec 15th, 2021 - The FDA granted a first-ever approval of a treatment to prevent acute graft-versus-host disease (aGVHD) in patients undergoing bone marrow or stem-cell transplantation. The approval allows use of abatacept (Orencia) in combination with certain imm...
https://www.onclive.com/view/preoperative-immunotherapy-sends-positive-signals-in-2-nsclc-studies
Dec 20th, 2020 - David J. Kwiatkowski, MD, PhD Neoadjuvant immunotherapy demonstrated substantial activity with a favorable toxicity profile in findings from 2 studies of patients with operable early-stage non—small cell lung cancer (NSCLC) reported at the 2019 A...
https://www.mdedge.com/obgyn/article/58987/womens-health/fda-warns-about-magnesium-sulfate-effects-newborns
Elizabeth Mechcatie
May 31st, 2013 - Magnesium sulfate should not be used for more than 5-7 days in pregnant women in preterm labor, because in utero exposure may lead to hypocalcemia and an increased risk of osteopenia and bone fractures in newborns, the Food and Drug Administration.
https://www.medpagetoday.com/obgyn/pregnancy/39486
May 30th, 2013 - The FDA today advised clinicians not to give pregnant women magnesium sulfate to prevent preterm labor for more than 5 to 7 days because it may harm developing fetal bones. Longer off-label administration of magnesium for tocolysis, which is appro...
https://www.medscape.com/viewarticle/778787
Feb 6th, 2013 - The Study and Background The Study Khan AM, Lubitz SA, Sullivan LM, et al. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study. Circulation. 2013;127:33-38. Background Nephrologists do not fr...